معرفی
Ulrich Bierbach is a Professor in the Department of Chemistry at Wake Forest University. His research focuses on developing platinum-acridine hybrid agents (PAHAs) for cancer therapy, exploring their unique DNA-binding mechanisms and tumor-targeted delivery systems. He has received multiple accolades including the Wake Forest Award for Excellence in Research (2005), Levison Family Faculty Fellowship (2016-2019), and URECA Award (2023).
- Education:
- Diplom in Chemistry (1989), University of Oldenburg, Germany
- Ph.D. in Chemistry (1992), University of Oldenburg (Advisor: S. Pohl)
- Postdoctoral Fellow (DFG, 1992-1993), Leiden University
- DFG Research Fellow (1994-1996), Virginia Commonwealth University (Advisor: Nicholas Farrell)
- Research Associate (1996-1998), Virginia Commonwealth University
- Postdoctoral Research Associate (1998-1999), University of Minnesota (Advisor: Lawrence Que, Jr.)
Research Interests center on:
- Design of mixed organic-inorganic anticancer drugs
- Mechanistic studies of DNA-metal interactions
- Computational tools for pharmacophore optimization
- Bioconjugate platforms for targeted delivery
- Structure-activity relationships in platinum agents
- Molecular modeling of drug-DNA complexes
Publication Trends show expertise in:
- Platinum-acridine hybrid compounds (1996-present)
- Development of DNA adduct detection methods (2014-2021)
- Novel formulations (liposomes, nanoparticles) (2016-2021)
- Mechanistic studies of cellular uptake and repair (2015-2023)
- Patent filings for drug design (3 issued patents)
Scientific Awards:
- Wake Forest Award for Excellence in Research (2005)
- Levison Family Faculty Fellowship (2016-2019)
- URECA Award for Excellence in Mentored Scholarship (2023)
Mentoring includes:
- Ph.D. graduates in platinum drug development
- MS students in DNA damage analysis
- Undergraduate researchers in inorganic-organic conjugate synthesis
- Postdoctoral fellows in drug delivery systems
Laboratory maintains:
- Interdisciplinary collaborations in pharmacology and bioinformatics
- Active research in drug-DNA interactions and formulation chemistry
- Commercialization partnerships for PAHA compounds
۰مقاله منتشرشده
